- Video: 2014 World TSC Conference: Lung Involvement in TSC and Treatment Options
- Video: 2014 World TSC Conference: Emerging Treatments -- mTOR Inhibitors and Beyond
- Video: How the American Recovery and Reinvestment Act funding is aiding Henske Lab’s research
- Video: Interview with Dr. Henske and other TSC experts about Clinical Trials in TSC
Elizabeth P. Henske, Director, Center for LAM Research and Clinical Care
The Henske Laboratory is focused on the genetics, cell biology and biochemistry of two tumor suppressor gene diseases: Tuberous Sclerosis Complex (TSC) and Birt-Hogg-Dube Syndrome (BHD). Our goal is to eliminate tumor cells and LAM cells in individuals living with these diseases as well as individuals with the sporadic forms of LAM and chromophobe RCC. Our mission is to translate research discoveries into improved clinical care, as quickly as possible, to improve the lives of those affected by these devastating diseases.